The management of a large pharmaceutical company with turnover of over 100M EUR wants to expand its presence in the EU and perform an acquisition of a manufacturing site. The buyer is based in Africa, although, it already has established a presence in Europe. The buyer is looking for any manufacturing unit.
The buyer is one of the leading pioneers in the North African pharmaceutical industry. The buyer currently has more than 500 well trained employees, who are experts in the pharmaceutical industry. The company takes pride in its high-quality production facilities, strong R&D department, and quality control lab equipment with the latest analytical Instruments.
The company owns product lines producing cream, ointment & gel with a capacity of 10 million tubes per year. Apart from that, the company production lines are able to manufacture liquid dosage solutions and suspensions with a production volume of 4 million bottles a year.
The company production site had expanded in recent years to around 10 thousand square meters. The product exposure of the company has recently shifted from local markets to international markets due to the recently issued ISO 9001 certiﬁcate and new partnerships and approvals. This is one of the reasons for the acquisition. The company is also planning to set up a new facility for hormone production.
Contact us to get details about this pharmaceutical manufacturing site buyer
This company is looking either for an acquisition but is also open to a joint venture. The target should operate in the pharmaceutical industry manufacturing site. The target country is not a decisive factor, though the main target countries for the buyer are:
The goal of the buyer is to acquire a fully regulatory compliant pharmaceutical manufacturing unit under running condition. The preferred number of employees of the target is between 20 and 30, generating a turnover of approximately 3M EUR.
The buyer has sufficient funds for acquisition, no additional bank financing will be required. The available budget for acquisition is 2-5 million EUR. The buyer company is open to any form of cooperation between the buyer and the target, including a joint venture, if that is in the best interests for both companies.
Feel free to contact us for more information regarding this pharmaceutical manufacturer site wanted in Europe, or if you know possible interested or suitable parties. For more buyers of pharmaceutical companies, please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.